Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given.

Delaying long-acting injectable ART for HIV with viremia may lead to thousands of preventable deaths. Modeling supports ...

The approval of cabotegravir plus rilpivirine (Cabenuva) in January 2021 was the first to provide both benefits as a monthly ...

Large numbers of vulnerable HIV patients in South Africa are feared to have dropped off medication, in what campaigners warn ...

The investigational tuberculosis vaccine M72/AS01E-4 has an acceptable safety profile and robust immunogenicity among ...

According to the Kaiser Family Foundation, the CDC funds 91% of domestic HIV prevention efforts. It represents a $794 million ...

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

A single shot of gene therapy given to newborn monkeys appears to shield them from HIV, the virus that causes AIDS, for at ...

Receiving treatment within the first month of life could protect children for at least three years, a study suggests.

Lori Cannon, a renowned Chicago activist and advocate for Chicago's LGBTQ+ community and people living with HIV/AIDS, died ...

In Colombia, Afro-descendant women are taking the HIV response into their own hands. Faced with racism, inequality and ...

Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by ...